Loading...
EKTAY
OTCM
Market cap2.18bUSD
Nov 20, Last price  
5.85USD
1D
-3.15%
1Q
-0.59%
Jan 2017
-32.60%
Name

Elekta AB (publ)

Chart & performance

D1W1MN
OTCM:EKTAY chart
P/E
—
P/S
1.31
EPS
—
Vol. 1Y
43.68%
Shs. 5Y
0.08%
Rev. 5Y
3.97%
Div Yld LY
4.23%
Div Yld TTM
4.33%
Revenues
16.72b
-7.20%
4,525,000,0005,081,000,0006,689,000,0007,392,000,0007,904,000,0009,048,000,00010,339,000,00010,694,000,00010,839,000,00011,221,000,00010,704,000,00011,333,000,00013,555,000,00014,601,000,00013,763,000,00014,548,000,00016,869,000,00018,119,000,00018,016,000,00016,718,000,000
Net income
-520m
L
348,000,000406,000,000546,000,000833,000,0001,031,000,0001,227,000,0001,340,000,0001,148,000,000552,000,000137,000,000125,000,0001,099,000,0001,198,000,0001,084,000,0001,254,000,0001,154,000,000943,000,0001,302,000,000237,000,000-520,000,000
CFO
2.46b
-6.17%
150,000,000319,000,000740,000,0001,056,000,000840,000,000635,000,0001,870,000,0001,275,000,0001,823,000,0001,170,000,0001,819,000,0002,404,000,0001,621,000,0001,014,000,0002,551,000,0001,858,000,0001,964,000,0002,461,000,0002,626,000,0002,464,000,000
Dividend
Sep 04, 20260.12363 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Elekta AB (publ) operates as a global medical technology company, delivering advanced clinical solutions for managing cancer and various brain disorders. Its extensive oncology offerings include sophisticated radiation therapy systems such as Versa HD, tailored for brain metastases; the groundbreaking Elekta Unity, leveraging MR-Linac technology; linear accelerators like Elekta Harmony; and Elekta Infinity, designed to address diverse radiotherapy needs. The company also provides Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy. Beyond primary treatment devices, Elekta supplies comprehensive treatment management solutions, automated and integrated quality assurance tools, and hardware/software for motion management. Specialized oncology platforms feature MOSAIQ Plaza for multidisciplinary cancer care, the managed hosting service Elekta Axis Cloud, and Elekta Studio for image-guided brachytherapy. Complementary hardware includes the ImagingRing mobile CT scanner. For brachytherapy, they offer smart tools like Oncentra Brachy to streamline repetitive tasks, alongside applicators such as Venezia and Geneva for cervical cancer treatment, and the Elekta Flexitron afterloader for precise workflow execution. In the field of neurosurgery and radiosurgery, Elekta provides the Leksell Gamma Knife series, including Icon for personalized radiation treatment, Perfexion as a vital tool for neurosurgeons, and Lightning for accelerated radiosurgery. Their neurosurgery product line further encompasses the Leksell Vantage Stereotactic System for intracranial procedures and the Leksell Stereotactic System for minimally invasive interventions. Elekta AB (publ) was founded in 1972 and is headquartered in Stockholm, Sweden.

Related entities

Subsidiaries (2)
Elekta Instrument AB
Elekta Solutions AB

Key people

Laurent Leksell
Chairman of the Board · since 2022
Klara Eiritz
Chief Financial Officer, Member of the Executive Committee · since 2026
Anna Lundgren
Executive Vice President, Chief People Officer, Member of the Executive Committee · since 2023
Jonas Bolander
Executive Vice President - Group Functions, General Counsel, Member of the Executive Committee · since 2025
Christopher Busch
President - Linac & Software Solutions, Member of the Executive Committee · since 2024
John Lapre
President - Brachy & Neuro Solutions, Member of the Executive Committee · since 2023
Habib Nehme
Chief Commercial Officer, Member of the Executive Committee · since 2023
Independent Director · since 2024
Independent Director · since 2023
Jan Kimpen
Independent Director · since 2024
Wolfgang Reim
Independent Director · since 2011
Jan Secher
Independent Director · since 2010
Volker Wetekam
Independent Director · since 2023
Cecilia Wikstroem
Independent Director · since 2018
IPO date
Mar 01, 1994
Employees
4,700
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Box 7593
Stockholm, AB 103 93
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑042025‑042024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT